Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vijay D. Wagh"'
Autor:
Vijay D. Wagh, Dipak U. Apar
Publikováno v:
Journal of Nanotechnology, Vol 2014 (2014)
Dry eye disease is a common disease of the tear film caused by decreased tear production or increased evaporation. The objective of this study was to develop and evaluate poly (dl-lactide-co-glycolide) (PLGA) nanoparticles for CsA (CsA) ophthalmic de
Externí odkaz:
https://doaj.org/article/cf38fbc860f5423e8acb2d944dc02ba7
Autor:
Vijay D. Wagh
Publikováno v:
Advances in Pharmacological Sciences, Vol 2013 (2013)
Externí odkaz:
https://doaj.org/article/326bc263350747ea9bd094766af42d65
Autor:
Vijay D. Wagh, Onkar J. Deshmukh
Publikováno v:
ISRN Pharmaceutics
Niosomes have potential applications in topical drug delivery system. The objective of the study was to formulate and evaluate the niosome of Itraconazole. Surfactant : cholesterol ratio and quantity of ethanol used were studied by applying factorial
Autor:
Vijay D. Wagh, Nilesh Pawar
Publikováno v:
ISRN Pharmaceutics
An attempt was made to sustain the release of Betahistine hydrochloride by complexation technique using strong cation-exchange resin, Tulsion T344. The drug loading onto ion-exchange resin was optimized for mixing time, activation, effect of pH, swel
Autor:
Dipak U. Apar, Vijay D. Wagh
Publikováno v:
Journal of Nanotechnology, Vol 2014 (2014)
Dry eye disease is a common disease of the tear film caused by decreased tear production or increased evaporation. The objective of this study was to develop and evaluate poly (dl-lactide-co-glycolide) (PLGA) nanoparticles for CsA (CsA) ophthalmic de
Publikováno v:
Journal of Postgraduate Medicine, Vol 58, Iss 3, Pp 199-202 (2012)
Forskolin is the first pharmaceutical drug and product derived from a plant to be approved in India by the DCGI in 2006. Forskolin (7beta-acetoxy-8, 13-epoxy-1a, 6β, 9a-trihydroxy-labd-14-en-11-one) is a diterpenoid isolated from plant Coleus forsko
Autor:
Sandeep G Jakhere, Vijay D. Wagh
Publikováno v:
Journal of Postgraduate Medicine, Vol 57, Iss 1, Pp 48-50 (2011)
Hirayama′s disease is a form of juvenile muscular atrophy affecting young individulas in their second to third decade. The underlying pathogenetic mechanism is believed to be an imbalanced growth between the individuals′ vertebral column and the
In vitro methods to determine bioavailability & IVIVC of oral dosage forms and drug delivery systems
Autor:
Vijay D. Wagh
Publikováno v:
Journal of Bioequivalence & Bioavailability.